Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: Evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 1, 2006, Pages 395-401

  Zanotti, Ilaria ^a   Potì, Francesco ^a   Favari, Elda ^a   Steffensen, Knut R ^b   Gustafsson, Jan Åke ^b   Bernini, Franco ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

22 HYDROXYCHOLESTEROL; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ABC TRANSPORTER A1; CHOLESTEROL; CYCLIC AMP; GERANYLGERANIOL; LIVER X RECEPTOR; MESSENGER RNA; MEVALONIC ACID; PHOSPHOLIPID; PITAVASTATIN; RETINOIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EFFUSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELLS, CULTURED; CHOLESTEROL; CYCLIC AMP; DNA-BINDING PROTEINS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID METABOLISM; MACROPHAGES, PERITONEAL; MICE; PHOSPHOLIPIDS; QUINOLINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33645127043     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.093930     Document Type: Article

References (38)

1. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, and Gustafsson JA (2001) Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice. J Clin Investig 107:565-573.
2. Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, and Fujimura A (2004) Effects of pravastatin on ATP-binding cassette transporter A1. J Pharmacol Exp Ther 311:420-425.
3. Arakawa R, Hayashi M, Remaley AT, Brewer BH, Yamauchi Y, and Yokoyama S (2004) Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J Biol Chem 279:6217-6220.
4. Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, and Huff MW (2005) Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem 280:22212-22221.
5. Bernini F, Canavesi M, Bernardini E, Scurati N, Bellosta S, and Fumagalli R (1997) Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies. Br J Pharmacol 122:1209-1215.
6. Bernini F, Scurati N, Bonfadini G, and Fumagalli R (1995) HMG-CoA reductase inhibitors reduce acetyl LDL endocytosis in mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol 15:1352-1358.
7. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, and Francone OL (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275:28634-28640.
8. Brown MS, Faust J, Goldstein JL, Kaneko I, and Endo A (1978) Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 253:1121-1128.
9. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, et al. (2001) PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58.
10. Clee SM, Kastelein JJ, and van Dam MJ (2000) Age and residual cholesterol efflux affect HDL cholesterol level and coronary artery disease in ABCA1 heterozygotes. J Clin Investig 106:1263-1270.
11. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, and Bernini F (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84:413-428.
12. Costet P, Luo Y, Wang N, and Tall AR (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275:28240-28245.
13. Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, and Rothblat GH (2004) Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol 24:2345-2350.
14. Feng B and Tabas I (2002) ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages: mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 277:43271-43280.
15. Forman BM, Ruan B, Chen J, Schroepfer GJ Jr, and Evans RM (1997) The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci USA 94:10588-10593.
16. Goldstein JL and Brown MS (1990) Regulation of the mevalonate pathway. Nature (Lond) 343:425-430.
17. Haidar B, Denis M, Krimbou L, Marcil M, and Genest J Jr (2002) cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 43:2087-2094.
18. Iverson SJ, Lang SL, and Cooper MH (2001) Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids 36:1283-1287.
19. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2003) Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 44: 1728-1736.
20. Kiss RS, Maric J, and Marcel YL (2005) Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J Lipid Res 46:1877-1887.
21. Kjekshus J, Pedersen TR, and Tobert JA (1996) Lipid-lowering therapy for patients with or at risk of coronary artery disease. Curr Opin Cardiol 11:418-427.
22. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, and Schmitz G (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 257:29-33.
23. Morello F, de Boer RA, Steffensen KR, Gnecchi M, Chisholm JW, Boomsma F, Anderson LM, Lawn RM, Gustafsson JÅ, Lopez-Ilasaca M, et al. (2005) Liver X receptors a and b regulate renin expression in vivo. J Clin Investig 115:1913-1922.
24. Mukhtar RY, Reid J, and Reckless JP (2005) Pitavastatin. Int J Clin Pract 59:239-252.
25. Oram JF (2003) HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23:720-727.
26. Rosenson RS and Tangney CC (1998) Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. J Am Med Assoc 279:1643-1650.
27. Schmitz G and Langmann T (2001) Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 12:129-140.
28. Schmitz G and Langmann T (2005) Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 1735:1-19.
29. Singaraja RR, Bocher V, James ER, Clee SM, Zhang LH, Leavitt BR, Tan B, Brooks-Wilson A, Kwok A, Bissada N, et al. (2001) Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem 276:33969-33979.
30. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, and Hayden MR (2003) Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23:1322-1332.
31. Sone H, Shimano H, Shu M, Nakakuki M, Takahashi A, Sakai M, Sakamoto Y, Yokoo T, Matsuzaka K, Okazaki H, et al. (2004) Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages. Biochem Biophys Res Commun 316:790-794.
32. Srivastava N (2002) ATP binding cassette transporter A1: key roles in cellular lipid transport and atherosclerosis. Mol Cell Biochem 237:155-164.
33. van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AH, Groen AK, et al. (2002) Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359:37-41.
34. Wang XQ, Panousis CG, Alfaro ML, Evans GF, and Zuckerman SH (2002) Interferon-γ-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway. Arterioscler Thromb Vasc Biol 22:e5-e9.
35. Wong J, Quinn CM, and Brown AJ (2004) Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol flux. Arterioscler Thromb Vasc Biol 24:1-7.
36. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, and Rothblat GH (1995) Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 34:7955-7965.
37. Yancey PG, Bortnick AE, Kellner-Weibel G, de la Lera-Moya M, Phillips MC, and Rothblat GH (2003) Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23:712-719.
38. Zanotti I, Favari E, Sposito AC, Rothblat GH, and Bernini F (2004) Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells. Biochem Biophys Res Commun 321:670-674.